Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAPDH | P04406 | 4/20 | 0.65 |
| ▸ | CES2 | O00748 | 7/20 | 0.59 |
| ▸ | CES1 | P23141 | 7/20 | 0.59 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | P4HB | P07237 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13879154 | 0.81 | CES2 (0.64) | GAPDHCES2CES1HKDC1NSD2 | |
| SCHEMBL4468407 | 0.78 | GAPDH (1.00) | GAPDHCES2CES1HKDC1NSD2 | |
| SCHEMBL8720193 | 0.78 | LTA4H (0.61) | GAPDHCES2CES1HKDC1NSD2 | |
| SCHEMBL6432470 | 0.73 | LTA4H (0.55) | GAPDHCES2CES1HKDC1NSD2 | |
| SCHEMBL17594909 | 0.72 | GAPDH (0.89) | GAPDHCES2CES1NSD2P4HB | |
| SCHEMBL1802680 | 0.72 | NSD2 (0.73) | GAPDHCES2CES1HKDC1NSD2 | |
| SCHEMBL28721937 | 0.71 | GAPDH (0.68) | GAPDHCES2CES1HKDC1NSD2 | |
| SCHEMBL3363900 | 0.69 | MAOA (0.55) | GAPDHCES2CES1LTA4HTSHR | |
| Anthraquinone SCHEMBL3750915 | 0.69 | NSD2 (0.58) | GAPDHCES2CES1HKDC1NSD2 | |
| SCHEMBL6256773 | 0.66 | LTA4H (0.50) | GAPDHCES2CES1HKDC1NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114007649-A | Targeted synergistic cancer immunotherapy | 布里格姆及妇女医院股份有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-114007649-A | Targeted synergistic cancer immunotherapy | 布里格姆及妇女医院股份有限公司 | 2022-02-01 | — | — | CN | disclosed |